References
- Goodwin C.S., Armstrong J.A., Chilvers T., Peters M., Collins M.D., Sly L., McConnell W., Harper W.E.: Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov., as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., respectively. Int. J. Syst. Bacteriol., 1989; 39: 397-405
- De Witte C., Schulz C., Smet A., Malfertheiner P., Haesebrouck F.: Other Helicobacters and gastric microbiota. Helicobacter, 2016; 21: 62-68
- Taniguchi T., Yamazaki W., Saeki Y., Takajo I., Okayama A., Hayashi T., Misawa N.: The pathogenic potential of Helicobacter cinaedi isolated from non-human sources: Adherence, invasion and translocation ability in polarized intestinal epithelial Caco-2 cells in vitro. J. Vet. Med. Sci., 2016; 78: 627-632
- Nakamura I., Ohkusu K., Nakagami Y., Tachibana M., Matsumoto T.: First case report of bacteremia due to ‘Campylobacter-like organism 3’. Int. J. Infect. Dis., 2016; 42: 51-53
- Uwamino Y., Muranaka K., Hase R., Otsuka Y., Hosokawa N.: Clinical features of community acquired Helicobacter cinaedi bacteremia. Helicobacter, 2016; 21: 24-28
- Epstein S.E.: The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ. Res., 2002; 90: 2-4
- Michelsen K.S., Doherty T.M., Shah P.K., Arditi M.: TLR signaling: An emerging bridge from innate immunity to atherogenesis. J. Immunol., 2004; 173: 5901-5907
- Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Mäkelä P.H., Huttunen J.K., Valtonen V.: Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, 1988; 2: 983-986
- Hajjar D.P., Pomerantz K.B., Falcone D.J., Weksler B.B., Grant A.J.: Herpes simplex virus infection in human arterial cells: Implications in arteriosclerosis. J. Clin. Invest., 1987; 80: 1317-1321
- Ameriso S.F., Fridman E.A., Leiguarda R.C., Sevlever G.E.: Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke, 2001; 32: 385-391
- Ziver T., Yuksel P., Ipek G., Yekeler I., Bayramoglu Z., Tireli E, Saribas S., Aslan M., Yalvac S.D., Ozdomanic I., et al.: Aneurysm and Helicobacter pylori relationship: The seropositivity of CagA, VacA and other antigens of Helicobacter pylori in abdominal and ascending aortic aneurysms. New Microbiol., 2010; 33: 233-242
- Khan S., Okamoto T., Enomoto K., Sakashita N., Oyama K., Fujii S., Sawa T., Takeya M., Ogawa H., Yamabe H., Akaike T.: Potential association of Helicobacter cinaedi with atrial arrhythmias and atherosclerosis. Microbiol. Immunol., 2012; 56: 145-154
- Oyama K., Khan S., Okamoto T., Fujii S., Ono K., Matsunaga T., Yoshitake J., Sawa T., Tomida J., Kawamura Y., Akaike T.: Identification of and screening for human Helicobacter cinaedi infections and carriers via nested PCR. J. Clin. Microbiol., 2012; 50: 3893-3900
- Zhu Y., Xian X., Wang Z., Bi Y., Chen Q., Han X., Tang D., Chen R.: Research progress on the relationship between atherosclerosis and inflammation. Biomolecules, 2018; 8: 80
- Libby P., Ridker P.M., Hansson G.K.: Progress and challenges in translating the biology of atherosclerosis. Nature, 2011; 473: 317325
- Gibson M.S., Domingues N., Vieira O.V.: Lipid and non-lipid factors affecting macrophage dysfunction and inflammation in atherosclerosis. Front. Physiol., 2018; 9: 654
- Araoka H., Baba M., Kimura M., Abe M., Inagawa H., Yoneyama A.: Clinical characteristics of bacteremia caused by Helicobacter cinaedi and time required for blood cultures to become positive. J. Clin. Microbiol., 2014; 52: 1519-1522
- Nakao S., Hagiya H., Kimura K., Mitsui T., Oyama A., Hongyo K., Takahashi Y., Nakagami F., Tomono K., Rakugi H.: Helicobacter cinaedi-associated carotid arteritis. Acta Med. Okayama, 2018; 72: 189-192
- Kawamura Y., Tomida J., Morita Y., Fujii S., Okamoto T., Akaike T.: Clinical and bacteriological characteristics of Helicobacter cinaedi infection. J. Infect. Chemother., 2014; 20: 517-526
- Lewis G.D., Holmes C.B., Holmvang G., Butterton J.R.: Case records of the Massachusetss General Hospital. Case 8-2007. A 48-year-old man with chest pain followed by cardiac arrest. N. Engl. J. Med., 2007; 356: 1153-1162
- Khan S., Rahman H.N., Okamoto T., Matsunaga T., Fujiwara Y., Sawa T., Yoshitake J., Ono K., Ahmed K.A., Rahaman M.M., et al.: Promotion of atherosclerosis by Helicobacter cinaedi infection that involves macrophage-driven proinflammatory responses. Sci. Rep., 2014; 4: 4680
- Unosawa S., Niino T.: An infected abdominal aortic aneurysm caused by Helicobacter cinaedi. Ann. Vasc. Dis., 2015; 8: 318-320
- Nishidai K., Iwasawa T., Tamura A., Lefor A.T.: Infected abdominal aortic aneurysm with Helicobacter cinaedi. Case Rep. Surg., 2016, 2016: 1396568
- D’Elios M.M., Vallese F., Capitani N., Benagiano M., Bernardini M.L., Rossi M., Rossi G.P., Ferrari M., Baldari C.T., Zanotti G., et al.: The Helicobacter cinaedi antigen CAIP participates in atherosclerotic inflammation by promoting the differentiation of macrophages in foam cells. Sci. Rep., 2017; 7: 40515
- Libby P., Ridker P.M., Hansson G.K., Leducq Transatlantic Network on Atherothrombosis: Inflammation in atherosclerosis: From pathophysiology to practice. J. Am. Coll. Cardiol., 2009; 54: 21292138
- Tabas I.: Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol., 2010; 10: 36-46